JP2008503221A5 - - Google Patents

Download PDF

Info

Publication number
JP2008503221A5
JP2008503221A5 JP2007516840A JP2007516840A JP2008503221A5 JP 2008503221 A5 JP2008503221 A5 JP 2008503221A5 JP 2007516840 A JP2007516840 A JP 2007516840A JP 2007516840 A JP2007516840 A JP 2007516840A JP 2008503221 A5 JP2008503221 A5 JP 2008503221A5
Authority
JP
Japan
Prior art keywords
prrsv
orf1
dna
combinations
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007516840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503221A (ja
Filing date
Publication date
Priority claimed from US11/154,617 external-priority patent/US7722878B2/en
Application filed filed Critical
Publication of JP2008503221A publication Critical patent/JP2008503221A/ja
Publication of JP2008503221A5 publication Critical patent/JP2008503221A5/ja
Withdrawn legal-status Critical Current

Links

JP2007516840A 2004-06-17 2005-06-17 Prrsvサブユニットワクチン Withdrawn JP2008503221A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58135004P 2004-06-17 2004-06-17
US11/154,617 US7722878B2 (en) 2004-06-17 2005-06-16 PRRSV subunit vaccines
PCT/US2005/021973 WO2006002193A2 (en) 2004-06-17 2005-06-17 Prrsv subunit vaccines

Publications (2)

Publication Number Publication Date
JP2008503221A JP2008503221A (ja) 2008-02-07
JP2008503221A5 true JP2008503221A5 (enExample) 2008-08-07

Family

ID=35431312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007516840A Withdrawn JP2008503221A (ja) 2004-06-17 2005-06-17 Prrsvサブユニットワクチン

Country Status (14)

Country Link
US (1) US7722878B2 (enExample)
EP (1) EP1755664B1 (enExample)
JP (1) JP2008503221A (enExample)
KR (1) KR20070028431A (enExample)
AR (1) AR049825A1 (enExample)
AU (1) AU2005258092A1 (enExample)
BR (1) BRPI0510930A (enExample)
CA (1) CA2570778A1 (enExample)
DK (1) DK1755664T3 (enExample)
ES (1) ES2546933T3 (enExample)
MX (1) MXPA06014821A (enExample)
RU (1) RU2007101531A (enExample)
TW (1) TW200603825A (enExample)
WO (1) WO2006002193A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
PL204373B1 (pl) 1999-03-08 2010-01-29 Boehringer Ingelheim Vetemendi Replikony zespołu reprodukcyjnego i oddechowego świń (PRRSV), zastosowanie replikonów PRRSV, szczepionki zawierające replikony PRRSV i zastosowanie tych szczepionek
ES2348159T3 (es) 1999-04-22 2010-11-30 United States Department Of Agriculture Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142.
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PL2369001T3 (pl) 2005-06-24 2017-06-30 Regents Of The University Of Minnesota Wirusy PRRS, ich klony zakaźne, mutanty i sposoby stosowania
US8436337B2 (en) 2009-05-12 2013-05-07 The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity Amorphous multi-component metallic thin films for electronic devices
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
SG192820A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Novel european prrsv strain
ES2553879T3 (es) 2011-02-17 2015-12-14 Boehringer Ingelheim Vetmedica Gmbh Procedimiento para la producción a escala comercial de PRRSV
WO2012129176A1 (en) * 2011-03-18 2012-09-27 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon
CA2834956C (en) 2011-05-07 2018-11-20 Laboratorio Avi-Mex, S.A. De C.V. Recombinant vaccine against prrs in a viral vector
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
JP6212125B2 (ja) 2012-11-12 2017-10-11 オレゴン ステイト ユニバーシティ アモルファス金属薄膜非線形抵抗器
EP2968513A2 (en) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
ES2729838T3 (es) 2013-12-20 2019-11-06 Boehringer Ingelheim Vetmedica Gmbh Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6773908B1 (en) * 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof

Similar Documents

Publication Publication Date Title
JP2008503221A5 (enExample)
Ali et al. Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus
EP4368202A3 (en) Attenuated viruses useful for vaccines
JP2018523668A5 (enExample)
Rayevskaya et al. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes
JP2012503011A5 (ja) 慢性c型肝炎ウイルス感染症のための酵母系免疫治療組成物
AR048596A1 (es) Atenuacion sinergica del virus de estomatitis vesiculosa, sus vectores y sus composiciones inmunogenas
JP2014534202A5 (enExample)
JP2018520997A5 (enExample)
JP2008530245A5 (enExample)
RU2007101531A (ru) Субъединичная вакцина против prrsv
JP2016509003A5 (enExample)
SG158155A1 (en) Methods to bypass cd+4 cells in the induction of an immune response
JP2002542827A5 (enExample)
JP2005237328A5 (enExample)
RU2013120979A (ru) Северо-американский вирус репродуктивно-респираторного синдрома свиней (prrs) и его применения
JP2013507107A5 (enExample)
WO2013082535A3 (en) Controlled-release peptide compositions and uses thereof
WO2002019968A3 (en) Genetically engineered co-expression dna vaccines, construction methods and uses thereof
RU2015113826A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
JP2009501901A5 (enExample)
JP2006512078A5 (enExample)
WO2009051823A3 (en) Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof
Brown et al. Sequence Note: HIV Type 1 Subtypes in Malaysia Include B, C, and E
Kim et al. Protection of olive flounder, Paralichthys olivaceus, against viral hemorrhagic septicemia virus (VHSV) by immunization with NV gene-knockout recombinant VHSV